Introduction
Stem cells are generally characterized as clonogenic, undifferentiated cells which have been derived from embryonic, fetal, and adult organisms [1] [2] [3] . These cells are capable of long-term self-renewal and they are unique in their potential to generate various types of tissues under proper in vitro and in vivo conditions [4] . Embryonic stem cells derived from embryoblasts are pluripotent -they are able to differentiate into cell types of all three germ layers. Moreover, they possess unlimited capacity for symmetric divisions that provide their long-term self-renewal [5] , though their utilization is restricted by ethical considerations in many countries [6] . For this reason, adult stem cells represent a promising and more acceptable tool for tissue engineering and regenerative medicine. They are characterized by multipotency (Figure 1 ), asymmetric division, and capacity for self-renewal [7] . Over the past few years, adult stem cells have been derived from various types of tissues, including bone marrow, umbilical cord blood, adipose tissue, skin, dental pulp, placenta, and other tissues [8] [9] [10] [11] [12] [13] . Adult stem cells are adherent and have a fibroblast-like morphology as well as having the ability to produce colony-forming units-fibroblast (CFU-F) when cultured in vitro [8] . These cells are heterogeneous and express a variety of surface markers including CD29, CD44, CD56, CD73, CD90, CD105, CD106, CD133, CD166, CD271, STRO-1, and Sca-1. On other hand, they are negative for haematopoietic and blood lineage markers, including CD14, CD31, CD34, CD45, and c-Kit. Moreover, majority of them do not express HLA Class II markers [4, [14] [15] [16] .
The most important impact of that stem cells may have in the area of regenerative medicine is their "healing" potential. They promote processes of tissue repair and the regeneration of diseased and destroyed tissues. They act not only through the processes of active transport, differentiation and incorporation into damaged tissue, but also by promotion of angiogenesis and by their antiinflammatory and antifibrotic properties. Stem cells also produce variety of biologically active molecules (soluble factors), thereby influencing their local environment (activation of resident cells).
Moreover, they interact with immune cells and modulate the host immune response [14, 17] .
Skeletal muscle also contains at least two distinct populations of adult stem cells -satellite cells and multipotent stem cells (Table 1 
Historical perspective
The regenerative potential of skeletal muscle was well documented in the 19 th century [18] , but the cellular basis of this process remained unknown until 1960s when Alexander Mauro detected mononucleated cells and named them satellite cells [19] . He hypothesized that satellite cells represent muscle progenitor cells capable of forming new muscle fibres after injury. This prediction was later confirmed by many researchers. Numerous studies performed in the 1960s and 1970s proved that satellite cells are mitotically inactive in mature muscle, but that they are activated in response to injury. In the 1990s and 2000s, multipotent muscle-derived stem cells were isolated and characterised. They became very attractive for tissue engineering and regenerative medicine [18] .
Satellite cells
Satellite cells were firstly described almost fifty years ago by Mauro according to their location and morphology in vivo [19] . They represent a population of undifferentiated mononuclear cells, which reside in a niche outside the sarcolemma, but within the basal lamina of muscle fibers (Figure 2 ). During embryogenesis, satellite cells migrate from the hypaxial edge of the dorsal part of the somite, that is, the dermomyotome [20] . Postnatally, these cells are characterized with high proliferative potential and they are involved in the process of myofiber enlargement. In mature organisms, satellite cells are quiescent. However, when muscle damage occurs, these cells should become activated to play pivotal role in myofibre reparation [21] .
The study performed by Seale et al. showed that satellite cells express the paired box (Pax) transcription factor Pax7, which is considered to be a key protein essential for myogenesis and satellite cells survival [22] . The presence of Pax7 is also necessary for production of other muscle regulatory factors -MyoD and Myf5 [23] . Moreover, Pax7 plays a crucial role in the processes of proliferation, differentiation, and selfrenewal [24] . Satellite cells also produce the paralog of Pax7 -Pax3 which was detected at a relatively high level only in some muscle types, e.g. diaphragm, most trunk muscles, and some limb muscles [25] . Both of these transcription factors have integrated functions during development of muscle [26] . Besides paired box transcription factors, satellite cells also express M-cadherin, c-Met, Foxk1, syndecans 3, 4, and CD106, while the expression of CD34 can not be considered as strict marker of human satellite cells [27] [28] [29] . However, a more reliable marker of satellite cells in human muscle is CD56 (neural cell adhesion molecule) [30] . The assessment of differentiation potential showed that skeletal muscle satellite cells are strictly monopotential -they are committed to myogenesis [31, 32] .
Multipotent muscle-derived stem cells
Multipotent muscle-derived stem cells represent a heterogeneous population of stem cells present in the skeletal muscle, including muscle-derived stem cells, muscle side population cells, myoendothelial cells, mesangioblasts and pericytes [28, 33] . The origin of these stem cells and their relationship to each other, as well as differentiation potential, has recently been extensively studied. These cells were characterized based on the expression of several markers, such as CD31, CD34, CD45, CD56, CD90, CD105, CD133, CD146, and c-Kit. It was shown that a majority of these cells were highly positive for Sca-1, but differ in the expression levels of other markers. These results suggest the existence of several distinct populations of multipotent musclederived stem cells [34] [35] [36] .
Muscle-derived stem cells (MDSCs) are localized at the periphery of myofibres, closely associated with blood vessels. They may be isolated from muscle biopsy after enzymatic digestion using the pre-plate technique, which is based on the varied propensity of the cells to adhere to the substrate. MDSCs are usually purified from heterogeneous population after 5-7 days [37] . These cells express Sca-1, STRO-1, CD13, CD29, CD44, CD59, CD73, CD90, CD105, CD106, and BCL-2. They are also positive for myogenic markers, including desmin and Myo-D. On the contrary, MDSCs do not express hematopoietic stem cells and other blood lineage markers, such as c-Kit, CD45, CD3, CD4, CD5, CD8, and CD14 [28, 38] . Reports pertaining to the production of CD34 differ: some authors have confirmed its production, while other authors consider MDSCs as CD34 negative cells [28, 39, 40] . It has been experimentally shown that MDSCs cultured in medium with a low serum concentration spontaneously differentiate into myotubes [37] . Moreover, under proper in vitro condition MDSCs undergo myogenic, cardiogenic, osteogenic, and chondrogenic differentiation. They have also hematopoietic potential [28, 41] .
Muscle side population cells (MSPCs) were first isolated from mouse skeletal muscle by fluorescenceactivated cell sorting (FACS) Hoechst-stained cells, as MSPCs have ability to exclude Hoechst 33342 dye [42] . These cells are heterogeneous, but the majority of them (>90%) are positive for Sca-1 and are negative for c-Kit, CD43, and CD45 [43] . Some authors demonstrated the expression of CD34 [44, 45] . Seale and co-workers considered MSPCs to be precursors of satellite cells [22] . More recently, it was shown that MPSCs express syndecan 4 and Pax7, suggesting a close relationship with satellite cells. MPSCs are also involved in the process of myofibre formation and repopulation of satellite cells niche [45] . The analysis of differentiation potential of MPSCs showed lower potential when compared to other MDSCs -they undergo differentiation to myogenic and hematopoietic lineages [28] .
Myo-endothelial cells are localized on the periphery of myofibres close to blood vessels. These cells were identified by immunohistochemistry and immuno-electron microscopy (later by FACS) using anitbody against CD34 [28, 46] . Majority of myoendothelial cells are Sca-1 positive. According to Péalt and co-workers they were CD31, CD34, CD56 and CD144 positive, and negative for CD45 [28] . On the other hand, results obtained by Tamaki and co-workers do not prove expression of CD31 and CD144 [46] . Moreover, these cells do not express c-Kit, CD14 and CD49. These inconsistencies represent opportunities for further comprehensive studies focusing on their characterization. The examination of their multilineage potential demonstrated the capacity for myogenic, cardiogenic, osteogenic and chondrogenic differentiation. Moreover, when transplanted in vivo, they differentiated into vascular endothelial cells and skeletal muscle fibres [47] .
Mesoangioblasts were first identified in the wall of the mouse embryonic dorsal aorta [48] . Later, mesoangioblasts were obtained from postnatal muscle tissues of animal and human origin. These cells express CD31, CD34, CD44, CD117 and CD146; but not CD45 or CD133 [49] . Main potential of mesoangioblasts was shown by Sampaolesi et al. who demonstrated the induction of functional amelioration of the dystrophic phenotype after mesoangioblast injection into mice dystrophic muscle tissue [50] . The multilineage potential (myogenic, cardiogenic, osteogenic, chondrogenic and adipogenic) was also proved [51] .
Pericytes are present in microvessels under the basal membrane nearby to endothelial cells, where they affect the vessel size through contraction of smooth muscle actin. They were isolated through their expression of N2 proteoglycan and alkaline phosphatase [52] . Phenotypic studies showed expression of CD13, CD44, CD73, CD90, CD146 and PDGFRB, but not markers of hematopoietic lineages, including CD34 and CD45. Moreover, pericytes are multipotent cells, meaning that they can form cells of myogenic, osteogenic, adipogenic and chondrogenic lineages [52, 53] .
Isolation and culture of muscle derived stem cells
Several attempts were made to develop a method for isolation of distinct stem cell populations from skeletal muscle. Currently, there are two main approaches. The first approach is based on specific labeling of cells by fluorochromes (in case of FACS) or by magnetic nanoparticles coated with antibodies against a particular surface antigen (in the case of magnetic cells sorting, MCS). FACS and MCS allow cell sorting according to their surface marker profiles [54, 55] . Several markers seem to be exclusive to these populations (e.g. PAX3 and PAX7 in satellite cells), whereas other markers are shared among various cell types. There are other limitations, too, such as changes in proliferation rate and cellular multipotency [41] . Moreover, it was demonstrated that these cells display a decreased healing potential when administrated in vivo [56] . Recently, the most utilized methodical approach to isolate stem cells from skeletal muscles is the pre-plate technique ( Figure 3 ) [57] . This method is based on the differing ability of cells to adhere to the cultivation substrate. The first fraction, which adhered to substrate, is composed predominantly of fibroblasts. These cells are known as rapidly adhering cells (RACs). Supernatant containing the myogenic fraction is transferred to new culture vessel. This fraction contains slowly adhering cells (SACs), including myoblasts, satellite cells, and multipotent musclederived stem cells [41] . Even though this method does not favor obtaining a homogenous population of cells, many investigators believe that such a "cocktail" of various stem cells seems to have better proliferation characteristics and regenerative potential in vivo [40, 56, 58] . After isolation, stem cells derived from skeletal muscle may be easily expanded under in vitro conditions. The most frequently used medium is Dulbecco's modified Eagle medium (D-MEM) supplemented with fetal bovine serum and/or horse serum in varying concentrations [34, 59] . Several authors supplemented their media with chick embryo extract or various growth factors (e.g. EHF, IGF-1, FGF-2) which enhance the proliferation activity of muscle-related stem cells [60, 61] . An overview of frequently used media and supplements used to cultivate stem cells derived from skeletal muscle is presented in Table 2 .
Potential for regenerative medicine

Regeneration of skeletal muscle
The application of stem cells derived from muscle tissue represents a new hope for patients suffering from musculoskeletal disorders, especially from Duchenne muscular dystrophy (DMD). Several clinical studies were carried out with allogenic myoblasts. It was shown that the application of normal skeletal myoblasts creates a reservoir of cells which restore the production of dystrophin [62, 63] . However, these findings were inadequate from clinical point of view, which was attributed to immune rejection and short-term survival of transplanted cells. In subsequent studies, the allogenic myoblasts were transplanted into immunosuppressed patients [64, 65] . Results from animal studies indicated that transplantation of MDSCs seem to be a more reliable therapy for DMD. Qu-Petersen et al. demonstrated restoration of dystrophin production in mdx mice (a mouse model of DMD which has a point mutation within its dystrophin gene) after transplantation of allogenic MDSCs [37] . Similar results were obtained by injecting satellite cells, mesoangioblasts and pericytes in high densities in to dystrophic muscle [52, 66, 67] . More recently, attention is focused on the use of genetically modified MDSCs, e.g. MDSC transduced to overexpress VEGF. VEGF-expressing cells do not increase the number of dystrophin-positive fibers but promote muscle regeneration through modulation of angiogenesis, regeneration and fibrosis [68] . However, safe and effective cell therapy by MDCs requires further investigation.
Regeneration of urinary sphincter
Stress urinary incontinence is serious health problem that affects many individuals of both sexes in middle and old age. It leads to decreasing quality of life and to social isolation. Stem cell therapy appears to be a promising technique to regenerate a deficient urethral sphincter. Lee Hams F-10 20% fetal bovine serum chick embryo extract [61] Hams F-12 15% fetal bovine serum - [90] M199 10% fetal bovine serum - [91] Modified custom-made MCDB medium 20% fetal bovine serum bFGF [36] significantly improved the leak point pressure in treated animals after 4 weeks [69] . Their group also proved improvement of sphincter contractility after allogenic muscle-derived progenitor cells injection into the denervated rat urethra [70] . More recently, Xu et al.
transplanted MDSCs in combination with biodegradable fibrin glue which improved their biological action [71] . The first clinical trial using MDSCs was carried out at the University of Toronto. Eight patients suffering from urinary incontinence received cell therapy of pure MDSCs. The onset of improvement was recorded between three and eight months after administration [72] . Later, they conducted a randomized, blinded study of MDSC therapy in twenty-nine females with stress urinary incontinence. MDSC were transplanted twice in a three-month interval through cystoscopicassisted transurethral injection. In half of them there was no leakage at 1 year of follow-up [73] . Several attempts in this respect were performed in Austria by team of Dr. Strasser who injected muscle progenitor cells under transurethral ultrasound guidance into the rhabdosphincter [74, 75] . However, an ethics issue was aroused due to an inspection which found that this study was not conducted according to Austrian law and to the standards of the International Conference on Harmonisation of Good Clinical Practice. Moreover, hundreds of their patients had serious side effects so results were retracted. Based on the foregoing, it will be necessary to conduct further studies to validate the safety of the therapy in its present form.
Regeneration of cardiac muscle
Myocardial infarction is among the most common causes of death in developed countries. Several authors demonstrated the potential of stem cells derived from skeletal muscles to differentiate into cardiomyocytes [41, 76] . Okada et al. [59] injected populations of myogenic endothelial cells into immune-deficient mice with induced acute myocardial infarction. They observed improvement in left ventricular function six weeks after administration. Moreover, transplanted cells generated robust engraftments within the infarcted myocardium, and also stimulated angiogenesis, attenuation of scar tissue, and proliferation and survival of endogenous cardiomyocytes [59] . More recently, Shibuya and coworkers transplanted stem cells isolated from tongue muscle into a mouse model of myocardial infarction. After three months they demonstrated that left ventricle remodeling was attenuated and the survival rate was improved compared with the control group [77] .
Regeneration of articular cartilage
Congenital anomalies, pathological processes and injuries may lead in the degeneration of hyaline cartilage. It is difficult to treat these patients because mature hyaline cartilage has a very limited self-healing potential and mitotic activity of chondrocytes is very low [78] . Small defects are regenerated by the migration of chondrocytes while full-thickness damage is healed by the formation of inferior fibrocartilage; in many cases, however, osteoarthritis develops and surgical intervention is the only option [79] . Chondrogenic potential of MDSCs has been intensively studied by many investigators [80, 81] . Adachi and co-workers reported healing of full-thickness cartilage defects by application of collagen gel with MDSCs [82] . [86] . Similar results were obtained with MDSCs secreting BMP4 cultured within gels containing collagen, fibrin, and gelatin [87] . The gelatinous form of scaffolding, colonized by MDSCs, may be used as filler for closing of bone cysts [41] .
Conclusions
The biological properties of MDSCs, including high proliferative potential, self-renewing ability, and plasticity make them a unique tool for tissue engineering and regenerative medicine. Recently, the data obtained from animal models and preclinical studies seem to be highly promising; researchers and clinicians are thus highly motivated to find a quick way to translate these successes into clinical practice. The main prerequisite for this translation requires reproducible methods of isolation and in vitro cultivation with minimal effect on the biological properties of the cells involved. Special attention should be paid to comprehensive characterization and output control of expanded cells. It will be also essential to find proper methods for their administration and to determine the effective dose. In addition, their potential clinical use may be limited by the ensuing immune response of the recipient organism, in case of allogenic transplantation.
It is known that adult stem cells have the potential to modulate immune responses (e.g. suppression of T-cell proliferation, suppression of cytotoxic effect of CD8+, inhibition of proliferation and differentiation of activated B lymphocytes, etc.). However, these mechanisms are only partially understood and, therefore, require extensive, on-going investigation. Taken together, MDSCs-based therapies may improve the healing of many pathological conditions due to injury or disease. However, further studies are warranted to assess the safety of skeletal muscle-derived stem cells.
